Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
Northeast · New York
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in New York (8,260,000 residents, 19,500,000 metro). Dense pharmacy network with CVS, Walgreens, Duane Reade, and Rite Aid on most blocks; major academic systems concentrate GLP-1 prescribing in endocrinology and obesity-medicine clinics.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in New York →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in New York →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in New York →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in New York →
New York is a northeast-region city with a population of 8,260,000 (19,500,000 in the broader metropolitan area). New York expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include NewYork-Presbyterian, NYU Langone, Mount Sinai, Northwell Health.
New York's Medicaid program is New York Medicaid. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.